Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
We report myocardial injury in 20 recombinant factor VIIa (rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated (p = 0.02). Myocardial infarction occurred in 10% vs 1% (p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa
- Salvador Cruz-Flores, Saint Louis University, 3635 Vista Ave. St. Louis , MO 63110cruzfls@slu.edu
Submitted December 26, 2006 - Reply from the Authors
- Rebecca M Sugg, University of Alabama at Birmingham, WP 155 619 19th Street South Birmingham, Alabama 35249rsugg@uabmc.edu
- James C Grotta
Submitted December 26, 2006 - Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa
- Stephan A Mayer, Columbia University, 710 West 168th Street, Box 39, New York, NY 10032sam14@columbia.edu
- On behalf of the FAST Trial Steering Committee
Submitted December 26, 2006
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Elevated troponin levels are associated with higher mortality following intracerebral hemorrhageAngela Hays, Michael N. Diringer et al.Neurology, May 08, 2006 -
Articles
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhageS. M. Davis, J. Broderick, M. Hennerici et al.Neurology, April 24, 2006 -
Articles
Neuroanatomic correlates of stroke-related myocardial injuryH. Ay, W. J. Koroshetz, T. Benner et al.Neurology, March 08, 2006 -
Case
Remarkable Recovery After a Large Thalamic-Midbrain Intracerebral and Intraventricular HemorrhageVishank Arun Shah, Batya Radzik, Jon Weingart et al.Neurology: Clinical Practice, March 11, 2020